These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
210 related articles for article (PubMed ID: 3102243)
1. Different human B cell subsets respond to interleukin 2 and to a high molecular weight B cell growth factor (BCGF). Vazquez A; Gérard JP; Olive D; Auffredou MT; Dugas B; Karray S; Delfraissy JF; Galanaud P Eur J Immunol; 1986 Dec; 16(12):1503-7. PubMed ID: 3102243 [TBL] [Abstract][Full Text] [Related]
2. Synergy of B cell growth factor and interleukin 2 in the proliferation of activated human B cells. Romagnani S; Giudizi GM; Maggi E; Almerigogna F; Biagiotti R; Del Prete G; Mazzetti M; Alessi A; Vercelli D; Ricci M Eur J Immunol; 1985 Dec; 15(12):1158-64. PubMed ID: 3936718 [TBL] [Abstract][Full Text] [Related]
3. B cell growth and differentiation factors interact with receptors distinct from the interleukin 2 receptor. Kehrl JH; Grove JH; Goldsmith PK; Fauci AS Eur J Immunol; 1986 Jul; 16(7):761-6. PubMed ID: 3013645 [TBL] [Abstract][Full Text] [Related]
4. A mitogenic factor, released by stimulated human mononuclear cells and distinct from interleukin 2 (IL 2), B cell growth factor (BCGF), and interleukin 1 (IL 1). Kasakura S; Taguchi M; Watanabe Y; Okubo T; Murachi T; Uchino H; Hanaoka M J Immunol; 1984 Dec; 133(6):3084-90. PubMed ID: 6238094 [TBL] [Abstract][Full Text] [Related]
5. Sequential effect of a high molecular weight B cell growth factor and of interleukin 2 on activated human B cells. Vazquez A; Auffredou MT; Gerard JP; Delfraissy JF; Galanaud P J Immunol; 1987 Oct; 139(7):2344-8. PubMed ID: 3116080 [TBL] [Abstract][Full Text] [Related]
6. Evidence for an association between CD23 and the receptor for a low molecular weight B cell growth factor. Gordon J; Webb AJ; Walker L; Guy GR; Rowe M Eur J Immunol; 1986 Dec; 16(12):1627-30. PubMed ID: 3028819 [TBL] [Abstract][Full Text] [Related]
7. Analysis of the role of interferon-gamma, interleukin 2 and a third factor distinct from interferon-gamma and interleukin 2 in human B cell proliferation. Evidence that they act at different times after B cell activation. Romagnani S; Giudizi GM; Almerigogna F; Biagiotti R; Alessi A; Mingari C; Liang CM; Moretta L; Ricci M Eur J Immunol; 1986 Jun; 16(6):623-9. PubMed ID: 3087756 [TBL] [Abstract][Full Text] [Related]
8. B cell hyperactivity in systemic lupus erythematosus: selectively enhanced responsiveness to a high molecular weight B cell growth factor. Delfraissy JF; Wallon C; Vazquez A; Dugas B; Dormont J; Galanaud P Eur J Immunol; 1986 Oct; 16(10):1251-6. PubMed ID: 3095124 [TBL] [Abstract][Full Text] [Related]
9. Comparative activation requirements of human peripheral blood, spleen, and lymph node B cells. Jelinek DF; Lipsky PE J Immunol; 1987 Aug; 139(4):1005-13. PubMed ID: 3112218 [TBL] [Abstract][Full Text] [Related]
10. Human B cell responsiveness to B cell growth factor after activation by phorbol ester and monoclonal anti-mu antibody. Suzuki T; Butler JL; Cooper MD J Immunol; 1985 Apr; 134(4):2470-6. PubMed ID: 2982946 [TBL] [Abstract][Full Text] [Related]
11. Development and characterization of a human B cell line that responds to B cell growth factor but not interleukin 2. Tseng CT; Springgate CF; Piela TH; Choi YS J Immunol; 1987 Apr; 138(8):2554-60. PubMed ID: 3031160 [TBL] [Abstract][Full Text] [Related]
12. Identification of a major 50-kDa molecular weight human B-cell growth factor with Tac antigen-inducing activity on B cells. Kawano M; Matsushima K; Oppenheim JJ Cell Immunol; 1987 Aug; 108(1):132-49. PubMed ID: 3111722 [TBL] [Abstract][Full Text] [Related]
13. Functional properties of two human B cell growth factor species separated by lectin affinity column. Dugas B; Vazquez A; Geŕard JP; Richard Y; Auffredou MT; Delfraissy JF; Fradelizi D; Galanaud P J Immunol; 1985 Jul; 135(1):333-8. PubMed ID: 3923105 [TBL] [Abstract][Full Text] [Related]
14. Reactivity of Leu-1+ tonsillar B cells to a high molecular weight B cell growth factor. Richard Y; Leprince C; Dugas B; Treton D; Galanaud P J Immunol; 1987 Sep; 139(5):1563-7. PubMed ID: 3114370 [TBL] [Abstract][Full Text] [Related]
15. Functional studies examining the subpopulation of human B lymphocytes responding to high molecular weight B cell growth factor. Ambrus JL; Chesky L; Stephany D; McFarland P; Mostowski H; Fauci AS J Immunol; 1990 Dec; 145(12):3949-55. PubMed ID: 2258603 [TBL] [Abstract][Full Text] [Related]
16. The effects of interleukin 1 on human B cell activation and proliferation. Falkoff RJ; Muraguchi A; Hong JX; Butler JL; Dinarello CA; Fauci AS J Immunol; 1983 Aug; 131(2):801-5. PubMed ID: 6602846 [TBL] [Abstract][Full Text] [Related]
17. Modulation of IL-2-induced human B cell proliferation in the presence of human 50-kDa B cell growth factor and IL-4. Vazquez A; Mills S; Maizel A J Immunol; 1989 Jan; 142(1):94-9. PubMed ID: 2783328 [TBL] [Abstract][Full Text] [Related]
18. B cell growth-promoting activity of recombinant human interleukin 4. Defrance T; Vanbervliet B; Aubry JP; Takebe Y; Arai N; Miyajima A; Yokota T; Lee F; Arai K; de Vries JE J Immunol; 1987 Aug; 139(4):1135-41. PubMed ID: 3112225 [TBL] [Abstract][Full Text] [Related]
19. Augmentation of normal and malignant B cell proliferation by monoclonal antibody to the B cell-specific antigen BP50 (CDW40). Ledbetter JA; Shu G; Gallagher M; Clark EA J Immunol; 1987 Feb; 138(3):788-94. PubMed ID: 3492534 [TBL] [Abstract][Full Text] [Related]
20. Heterogeneity of responsiveness of chronic lymphocytic leukemic B cells to B cell growth factor or interleukin 2. Hivroz C; Grillot-Courvalin C; Brouet JC; Seligmann M Eur J Immunol; 1986 Aug; 16(8):1001-4. PubMed ID: 3488907 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]